Despite the signature matches, it is both structurally and sequence-wise very dissimilar from rhomboids.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 5, no: 5 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: E9ACB8
Term | Name | Level | Count |
---|---|---|---|
GO:0005975 | carbohydrate metabolic process | 3 | 3 |
GO:0006066 | alcohol metabolic process | 3 | 3 |
GO:0006071 | glycerol metabolic process | 5 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0019400 | alditol metabolic process | 4 | 3 |
GO:0019751 | polyol metabolic process | 4 | 3 |
GO:0044237 | cellular metabolic process | 2 | 3 |
GO:0044238 | primary metabolic process | 2 | 3 |
GO:0044262 | obsolete cellular carbohydrate metabolic process | 3 | 3 |
GO:0044281 | small molecule metabolic process | 2 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:1901615 | organic hydroxy compound metabolic process | 3 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 7 |
GO:0004371 | glycerone kinase activity | 5 | 3 |
GO:0016301 | kinase activity | 4 | 3 |
GO:0016740 | transferase activity | 2 | 3 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 3 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 3 |
GO:0004175 | endopeptidase activity | 4 | 4 |
GO:0004252 | serine-type endopeptidase activity | 5 | 4 |
GO:0008233 | peptidase activity | 3 | 4 |
GO:0008236 | serine-type peptidase activity | 4 | 4 |
GO:0016787 | hydrolase activity | 2 | 4 |
GO:0017171 | serine hydrolase activity | 3 | 4 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 173 | 175 | PF00675 | 0.365 |
CLV_NRD_NRD_1 | 298 | 300 | PF00675 | 0.425 |
CLV_NRD_NRD_1 | 336 | 338 | PF00675 | 0.615 |
CLV_NRD_NRD_1 | 340 | 342 | PF00675 | 0.619 |
CLV_NRD_NRD_1 | 349 | 351 | PF00675 | 0.601 |
CLV_NRD_NRD_1 | 98 | 100 | PF00675 | 0.742 |
CLV_PCSK_KEX2_1 | 173 | 175 | PF00082 | 0.311 |
CLV_PCSK_KEX2_1 | 188 | 190 | PF00082 | 0.483 |
CLV_PCSK_KEX2_1 | 298 | 300 | PF00082 | 0.425 |
CLV_PCSK_KEX2_1 | 340 | 342 | PF00082 | 0.580 |
CLV_PCSK_KEX2_1 | 348 | 350 | PF00082 | 0.595 |
CLV_PCSK_KEX2_1 | 97 | 99 | PF00082 | 0.740 |
CLV_PCSK_PC1ET2_1 | 188 | 190 | PF00082 | 0.352 |
CLV_PCSK_SKI1_1 | 128 | 132 | PF00082 | 0.608 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.282 |
CLV_PCSK_SKI1_1 | 256 | 260 | PF00082 | 0.346 |
CLV_PCSK_SKI1_1 | 298 | 302 | PF00082 | 0.427 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.555 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.566 |
CLV_PCSK_SKI1_1 | 98 | 102 | PF00082 | 0.661 |
DOC_CYCLIN_RxL_1 | 337 | 347 | PF00134 | 0.339 |
DOC_MAPK_gen_1 | 337 | 344 | PF00069 | 0.334 |
DOC_MAPK_gen_1 | 38 | 48 | PF00069 | 0.416 |
DOC_MAPK_gen_1 | 52 | 62 | PF00069 | 0.270 |
DOC_MAPK_MEF2A_6 | 55 | 64 | PF00069 | 0.296 |
DOC_MAPK_RevD_3 | 323 | 338 | PF00069 | 0.282 |
DOC_PP2B_LxvP_1 | 263 | 266 | PF13499 | 0.581 |
DOC_PP2B_LxvP_1 | 282 | 285 | PF13499 | 0.613 |
DOC_USP7_MATH_1 | 108 | 112 | PF00917 | 0.487 |
DOC_USP7_MATH_1 | 114 | 118 | PF00917 | 0.456 |
DOC_USP7_MATH_1 | 217 | 221 | PF00917 | 0.651 |
DOC_USP7_MATH_1 | 300 | 304 | PF00917 | 0.618 |
DOC_WW_Pin1_4 | 11 | 16 | PF00397 | 0.258 |
LIG_14-3-3_CanoR_1 | 189 | 194 | PF00244 | 0.698 |
LIG_14-3-3_CanoR_1 | 256 | 265 | PF00244 | 0.549 |
LIG_14-3-3_CanoR_1 | 299 | 309 | PF00244 | 0.651 |
LIG_14-3-3_CanoR_1 | 41 | 47 | PF00244 | 0.380 |
LIG_14-3-3_CanoR_1 | 55 | 64 | PF00244 | 0.405 |
LIG_APCC_ABBA_1 | 46 | 51 | PF00400 | 0.320 |
LIG_BRCT_BRCA1_1 | 65 | 69 | PF00533 | 0.370 |
LIG_BRCT_BRCA1_1 | 70 | 74 | PF00533 | 0.384 |
LIG_CSL_BTD_1 | 353 | 356 | PF09270 | 0.345 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.422 |
LIG_FHA_1 | 219 | 225 | PF00498 | 0.654 |
LIG_FHA_1 | 270 | 276 | PF00498 | 0.570 |
LIG_FHA_1 | 302 | 308 | PF00498 | 0.656 |
LIG_FHA_2 | 29 | 35 | PF00498 | 0.349 |
LIG_FHA_2 | 77 | 83 | PF00498 | 0.281 |
LIG_FHA_2 | 87 | 93 | PF00498 | 0.392 |
LIG_FHA_2 | 99 | 105 | PF00498 | 0.461 |
LIG_LIR_Gen_1 | 259 | 269 | PF02991 | 0.561 |
LIG_LIR_Gen_1 | 58 | 69 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 259 | 264 | PF02991 | 0.556 |
LIG_LIR_Nem_3 | 303 | 308 | PF02991 | 0.655 |
LIG_LIR_Nem_3 | 58 | 64 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 82 | 86 | PF02991 | 0.444 |
LIG_PDZ_Class_1 | 365 | 370 | PF00595 | 0.466 |
LIG_RPA_C_Fungi | 169 | 181 | PF08784 | 0.496 |
LIG_SH2_PTP2 | 279 | 282 | PF00017 | 0.509 |
LIG_SH2_STAP1 | 292 | 296 | PF00017 | 0.525 |
LIG_SH2_STAT5 | 279 | 282 | PF00017 | 0.543 |
LIG_SH2_STAT5 | 331 | 334 | PF00017 | 0.355 |
LIG_SH3_1 | 350 | 356 | PF00018 | 0.408 |
LIG_SH3_3 | 350 | 356 | PF00018 | 0.414 |
LIG_Sin3_3 | 261 | 268 | PF02671 | 0.377 |
LIG_SUMO_SIM_anti_2 | 14 | 21 | PF11976 | 0.271 |
LIG_SUMO_SIM_par_1 | 14 | 21 | PF11976 | 0.363 |
LIG_SUMO_SIM_par_1 | 220 | 225 | PF11976 | 0.393 |
LIG_TRAF2_1 | 225 | 228 | PF00917 | 0.452 |
LIG_UBA3_1 | 60 | 67 | PF00899 | 0.399 |
LIG_WRC_WIRS_1 | 165 | 170 | PF05994 | 0.326 |
LIG_WRC_WIRS_1 | 73 | 78 | PF05994 | 0.413 |
MOD_CK1_1 | 247 | 253 | PF00069 | 0.426 |
MOD_CK2_1 | 222 | 228 | PF00069 | 0.454 |
MOD_CK2_1 | 76 | 82 | PF00069 | 0.328 |
MOD_CK2_1 | 86 | 92 | PF00069 | 0.481 |
MOD_GlcNHglycan | 105 | 111 | PF01048 | 0.634 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.513 |
MOD_GlcNHglycan | 142 | 145 | PF01048 | 0.446 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.446 |
MOD_GlcNHglycan | 239 | 242 | PF01048 | 0.304 |
MOD_GlcNHglycan | 246 | 249 | PF01048 | 0.454 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.545 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.464 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.607 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.437 |
MOD_N-GLC_1 | 189 | 194 | PF02516 | 0.436 |
MOD_N-GLC_1 | 218 | 223 | PF02516 | 0.430 |
MOD_NEK2_1 | 164 | 169 | PF00069 | 0.372 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.520 |
MOD_NEK2_1 | 301 | 306 | PF00069 | 0.623 |
MOD_NEK2_1 | 344 | 349 | PF00069 | 0.540 |
MOD_NEK2_1 | 76 | 81 | PF00069 | 0.327 |
MOD_PKA_1 | 188 | 194 | PF00069 | 0.438 |
MOD_PKA_1 | 98 | 104 | PF00069 | 0.586 |
MOD_PKA_2 | 188 | 194 | PF00069 | 0.369 |
MOD_PKA_2 | 98 | 104 | PF00069 | 0.719 |
MOD_PKB_1 | 97 | 105 | PF00069 | 0.564 |
MOD_Plk_1 | 189 | 195 | PF00069 | 0.377 |
MOD_Plk_1 | 218 | 224 | PF00069 | 0.424 |
MOD_ProDKin_1 | 11 | 17 | PF00069 | 0.265 |
TRG_ENDOCYTIC_2 | 165 | 168 | PF00928 | 0.493 |
TRG_ENDOCYTIC_2 | 279 | 282 | PF00928 | 0.547 |
TRG_ENDOCYTIC_2 | 331 | 334 | PF00928 | 0.475 |
TRG_ER_diArg_1 | 134 | 137 | PF00400 | 0.507 |
TRG_ER_diArg_1 | 172 | 174 | PF00400 | 0.439 |
TRG_ER_diArg_1 | 211 | 214 | PF00400 | 0.446 |
TRG_ER_diArg_1 | 340 | 343 | PF00400 | 0.472 |
TRG_ER_diArg_1 | 348 | 350 | PF00400 | 0.518 |
TRG_ER_diArg_1 | 367 | 370 | PF00400 | 0.517 |
TRG_ER_diArg_1 | 97 | 99 | PF00400 | 0.586 |
TRG_NLS_MonoExtC_3 | 336 | 341 | PF00514 | 0.521 |
TRG_PTS1 | 367 | 370 | PF00515 | 0.521 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IG61 | Leptomonas seymouri | 54% | 100% |
A0A1X0NK02 | Trypanosomatidae | 32% | 100% |
A0A3R7KGS4 | Trypanosoma rangeli | 32% | 100% |
A0A3S5H501 | Leishmania donovani | 89% | 100% |
A4H3C4 | Leishmania braziliensis | 67% | 99% |
A4HRP0 | Leishmania infantum | 89% | 100% |
C9ZJ23 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 100% |
E9AJK6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
V5BCY2 | Trypanosoma cruzi | 32% | 71% |